Thomas A. McCourt
2018
In 2018, Thomas A. McCourt earned a total compensation of $2.2M as President at Ironwood Pharmaceuticals, a 7% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $232,500 |
|---|---|
| Option Awards | $869,479 |
| Salary | $465,000 |
| Stock Awards | $549,641 |
| Other | $34,002 |
| Total | $2,150,622 |
McCourt received $869.5K in option awards, accounting for 40% of the total pay in 2018.
McCourt also received $232.5K in non-equity incentive plan, $465K in salary, $549.6K in stock awards and $34K in other compensation.
Rankings
In 2018, Thomas A. McCourt's compensation ranked 5,347th out of 14,244 executives tracked by ExecPay. In other words, McCourt earned more than 62.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,347 out of 14,244 | 63rd |
Division Manufacturing | 2,018 out of 5,765 | 65th |
Major group Chemicals And Allied Products | 737 out of 2,128 | 65th |
Industry group Drugs | 617 out of 1,817 | 66th |
Industry Pharmaceutical Preparations | 476 out of 1,391 | 66th |
Source: SEC filing on April 26, 2019.
McCourt's colleagues
We found five more compensation records of executives who worked with Thomas A. McCourt at Ironwood Pharmaceuticals in 2018.
2018
Peter Hecht
Ironwood Pharmaceuticals
Chief Executive Officer
2018
William Huyett
Ironwood Pharmaceuticals
Chief Operating Officer
2018
Mark Currie
Ironwood Pharmaceuticals
Chief Scientific Officer
2018
Halley Gilbert
Ironwood Pharmaceuticals
Chief Administrative Officer
2018
Gina Consylman
Ironwood Pharmaceuticals
Chief Financial Officer
News
Ironwood Pharmaceuticals CEO Thomas McCourt's 2021 pay jumps 158% to $8.8M
April 21, 2022
Ironwood Pharmaceuticals CEO Mark Mallon's 2020 pay falls 32% to $6.8M
April 22, 2021
Ironwood Pharmaceuticals CEO Mark Mallon receives $10M in 2019
April 21, 2020
Ironwood Pharmaceuticals CEO Peter Hecht's 2018 pay slips 14% to $5.2M
April 26, 2019